FPCP
Fort Point Capital Partners’s Stoke Therapeutics STOK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $856K | Buy |
75,434
+5
| +0% | +$57 | 0.06% | 151 |
|
2025
Q1 | $502K | Hold |
75,429
| – | – | 0.06% | 196 |
|
2024
Q4 | $832K | Hold |
75,429
| – | – | 0.09% | 141 |
|
2024
Q3 | $927K | Hold |
75,429
| – | – | 0.11% | 118 |
|
2024
Q2 | $1.02M | Hold |
75,429
| – | – | 0.13% | 111 |
|
2024
Q1 | $1.02M | Hold |
75,429
| – | – | 0.14% | 114 |
|
2023
Q4 | $397K | Hold |
75,429
| – | – | 0.06% | 196 |
|
2023
Q3 | $297K | Hold |
75,429
| – | – | 0.05% | 204 |
|
2023
Q2 | $802K | Hold |
75,429
| – | – | 0.11% | 105 |
|
2023
Q1 | $628K | Hold |
75,429
| – | – | 0.1% | 133 |
|
2022
Q4 | $696K | Sell |
75,429
-60,610
| -45% | -$559K | 0.11% | 118 |
|
2022
Q3 | $1.75M | Sell |
136,039
-23,961
| -15% | -$308K | 0.29% | 61 |
|
2022
Q2 | $2.11M | Hold |
160,000
| – | – | 0.35% | 54 |
|
2022
Q1 | $3.37M | Hold |
160,000
| – | – | 0.47% | 44 |
|
2021
Q4 | $3.84M | Buy |
+160,000
| New | +$3.84M | 0.52% | 44 |
|